Glycine, N-(aminoiminomethyl)-N-methyl-

CAS: 57-00-1

Ref. IN-DA00IA63

Product Information

• Name: Glycine, N-(aminoiminomethyl)-N-methyl-
• Synonyms: Creatine, creatine, Creatin, Kreatin, N-amidinosarcosine, Krebiozon, 2-(1-Methylguanidino)acetic acid, N-methyl-N-guanylglycine, methylglycocyamine, Creatine, hydrate, (alpha-Methylguanido)acetic acid, Pyrolysate, Creatine anhydrous, Methylguanidoacetic acid, N-carbamimidoyl-N-methylglycine, Phosphagen, alpha-Methylguanidino acetic acid, Creatine, anhydrous, 2-(1-methylcarbamimidamido)acetic acid, N-(aminoiminomethyl)-N-methylglycine, 2-[carbamimidoyl(methyl)amino]acetic acid, (.alpha.-Methylguanido)acetic acid, (N-methylcarbamimidamido)acetic acid, N-(Aminoiminomethyl)-N-methyl-glycine, ((amino(imino)methyl)(methyl)amino)acetic acid, 2-(amidinomethylamino)acetic acid, ((amino(imino)methyl)(methyl)amino)acetate, [[Amino(imino)methyl](methyl)amino]acetate, [[Amino(imino)methyl](methyl)amino]acetic acid, Methylguanidoacetate, (alpha-Methylguanido)acetate, (a-Methylguanido)acetic acid, Creatine, hydrate (Salt/Mix), 2-(Methylguanidino)ethanoic acid, N-[amino(imino)methyl]-N-methylglycine, [[Amino(imino)methyl](methyl)amino]acetic acid #, Creatine hydrate, Unknown Ligand, n-amidinosarcosin, Creatine monohydrate, Creatine (Parkinson's disease), Avicena, Creatine (Huntington's disease), Avicena, Creatine (amyotrophic lateral sclerosis), Avicena, (1-Methylguanidino)acetic acid, (N-Methyl-guanidino)-acetic acid, 2-(N-Methylcarbamimidamido)acetic acid, 2-[(C-Azaniumylcarbonimidoyl)-methylamino]acetate, 5-Chloro-2-Maino Benzotrifluoride, Cosmocair C 100, Creatine preparation, Kre-Alkalyn, N-(Aminoiminomethyl)-N-methylglycine, N-Amidinosarkosin, N-Methyl-N-guanylglycine, N-amidinosarcosina, Neotine, Nsc 8752, Tego Cosmo C 100, Vitargo, [N-(Amidino)-N-methylamino]acetic acid
• Brand: Indagoo

Chemical properties

• Molecular weight: 131.1332
• Formula: C₄H₉N₃O₂
• Purity: 99%
• Color/Form: Solid
• InChI: InChI=1S/C4H9N3O2/c1-7(4(5)6)2-3(8)9/h2H2,1H3,(H3,5,6)(H,8,9)
• InChI key: CVSVTCORWBXHQV-UHFFFAOYSA-N